Brazil's National Health Surveillance Agency (Anvisa) has approved the use of the drug donanemabe to slow the progression of ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

In Vienna, the audience learned that the treatment dramatically shifted AD biomarkers ... This person had superficial siderosis, which indicates cerebral amyloid angiopathy and a weakened ...

On February 28, 2025, Terry Hamann of Milwaukee, WI, passed away after multiple years of battling debilitating strokes brought upon by the disease Cerebral Amyloid Angiopathy. Terry was 75 years old.

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Panelists discuss how managing patients with mild cognitive impairment using amyloid-targeting therapies faces significant barriers including limited healthcare infrastructure for complex diagnostic ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

Panelists discuss how developing effective management protocols for amyloid-related imaging abnormalities (ARIA) requires implementing robust baseline and follow-up MRI monitoring schedules, ...

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis ...

The 88-year-old pontiff and Vance had an awkward exchange at the Vatican on Easter Sunday after Francis slammed the Trump administration's treatment of illegal migrants. It came just one day ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...